Corient Private Wealth LLC Sells 4,405 Shares of CME Group Inc. $CME

Corient Private Wealth LLC lessened its stake in shares of CME Group Inc. (NASDAQ:CME) by 4.5% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 93,113 shares of the financial services provider’s stock after selling 4,405 shares during the quarter. Corient Private Wealth LLC’s holdings in CME Group were worth $25,664,000 as of its most recent SEC filing.

Several other institutional investors also recently modified their holdings of CME. Webster Bank N. A. grew its position in CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 60 shares during the last quarter. Highline Wealth Partners LLC raised its position in CME Group by 84.3% in the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares during the last quarter. Sagard Holdings Management Inc. acquired a new stake in shares of CME Group during the second quarter valued at about $30,000. Trifecta Capital Advisors LLC grew its holdings in shares of CME Group by 59.2% during the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock worth $31,000 after purchasing an additional 42 shares during the last quarter. Finally, Ransom Advisory Ltd bought a new stake in shares of CME Group during the first quarter worth about $31,000. 87.75% of the stock is currently owned by institutional investors and hedge funds.

CME Group Trading Up 0.3%

CME opened at $273.74 on Thursday. CME Group Inc. has a twelve month low of $224.62 and a twelve month high of $290.79. The company has a fifty day moving average of $272.42 and a 200-day moving average of $272.03. The stock has a market cap of $98.71 billion, a PE ratio of 26.53, a price-to-earnings-growth ratio of 4.07 and a beta of 0.28. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CME) last issued its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating analysts’ consensus estimates of $2.63 by $0.05. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The business had revenue of $1.54 billion for the quarter, compared to analysts’ expectations of $1.56 billion. During the same quarter in the prior year, the firm posted $2.68 earnings per share. The business’s quarterly revenue was down 3.0% compared to the same quarter last year. On average, sell-side analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be paid a dividend of $1.25 per share. The ex-dividend date of this dividend is Friday, December 12th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio (DPR) is currently 48.45%.

Analyst Ratings Changes

CME has been the subject of a number of research reports. UBS Group dropped their price objective on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a report on Thursday, October 23rd. Deutsche Bank Aktiengesellschaft upped their price target on shares of CME Group from $310.00 to $318.00 and gave the company a “buy” rating in a research report on Wednesday. TD Cowen lifted their price target on shares of CME Group from $288.00 to $290.00 and gave the stock a “hold” rating in a report on Thursday, October 23rd. Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a research note on Wednesday, October 8th. Finally, Keefe, Bruyette & Woods increased their price objective on CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. Eight research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and three have assigned a Sell rating to the company. According to MarketBeat, CME Group has an average rating of “Hold” and an average target price of $290.47.

Insiders Place Their Bets

In other CME Group news, Director William R. Shepard purchased 262 shares of the company’s stock in a transaction on Thursday, September 25th. The shares were purchased at an average cost of $265.19 per share, with a total value of $69,479.78. Following the completion of the purchase, the director owned 258,459 shares in the company, valued at $68,540,742.21. This represents a 0.10% increase in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Harold Eugene Jr. Ford sold 1,000 shares of the stock in a transaction that occurred on Monday, November 3rd. The stock was sold at an average price of $263.53, for a total value of $263,530.00. Following the transaction, the director owned 1,091 shares in the company, valued at $287,511.23. The trade was a 47.82% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.30% of the stock is currently owned by corporate insiders.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.